Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib
Apply
Venetoclax & Revumenib
A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step